E. Carmack Holmes - Director, Cytori Therapeutics, Inc

As of May 20, 2014


E. Carmack Holmes Net Worth

  • Net worth is estimated to be at least $265.44K
  • Owns at least 27,401 units of Cytori Therapeutics, Inc stock
  • Sold an estimated value of $181.26K in the last 8 years at Cytori Therapeutics, Inc

E. Carmack Holmes Trading

  • Largest purchase of shares was 20,000 units , worth over $65.9K on January 21, 2010
  • Largest sale of shares was 20,000 units , worth over $181.26K on January 21, 2010
  • In total has made about 15 transactions over 8 years
  • Usually trades in January and February, with the busiest year in 2010
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

E. Carmack Holmes Mailing Address

  • Mailing address is Ucla Dept of Surgery 10835 Lecente Ave Los Angeles CA 90095 CA

Cytori Therapeutics, Inc Insider Trading

  • The most recent transaction was 473,831 units sold on February 15, 2018 by Postfinance Ag worth over $161.01K
  • In the last 13 years, insiders at Cytori Therapeutics, Inc sold an estimated value of $5.03M and bought an estimated value of $20.46M
  • The most active traders are David Rickey, Director,  Christopher J Calhoun, Chief Executive Officer,  and Marc H Hedrick, President and CEO
  • Insider trading is most common in February, with the busiest year in 2006

CYTORI THERAPEUTICS, INC. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1